ResearcherChina Medical UniversityActive in the last 2 years

Fei‐Ting Hsu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2153-340X; OpenAlex author ID A5007195542. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 1 paper

Papers 2

Harnessing the Power of Sugar-Based Nanoparticles: A Drug-Free Approach to Enhance Immune Checkpoint Inhibition against Glioblastoma and Pancreatic Cancer. Co-author DOI 10.1021/acsnano.4c07903 ↗
Synergistic effect of Abraxane that combines human IL15 fused with an albumin-binding domain on murine models of pancreatic ductal adenocarcinoma. Co-author DOI 10.1111/jcmm.17220 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Chih‐Chia Huang · 1 shared paper, 2024 · strength 0.16
- Paper Harnessing the Power of Sugar-Based Nanoparticles: A Drug-Free Approach to Enhance Immune Checkpoint Inhibition against… DOI 10.1021/acsnano.4c07903 ↗
Li-Chan Chang · 1 shared paper, 2024 · strength 0.16
- Paper Harnessing the Power of Sugar-Based Nanoparticles: A Drug-Free Approach to Enhance Immune Checkpoint Inhibition against… DOI 10.1021/acsnano.4c07903 ↗
Wen‐Pin Su · 1 shared paper, 2024 · strength 0.16
- Paper Harnessing the Power of Sugar-Based Nanoparticles: A Drug-Free Approach to Enhance Immune Checkpoint Inhibition against… DOI 10.1021/acsnano.4c07903 ↗
Keng-Li Lan · 1 shared paper, 2022 · strength 0.16
- Paper Synergistic effect of Abraxane that combines human IL15 fused with an albumin-binding domain on murine models of pancre… DOI 10.1111/jcmm.17220 ↗
Yee Chao · 1 shared paper, 2022 · strength 0.16
- Paper Synergistic effect of Abraxane that combines human IL15 fused with an albumin-binding domain on murine models of pancre… DOI 10.1111/jcmm.17220 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.